Am. J. Respir. Crit. Care Med., Volume 159, Number 6, June 1999, 1843-1848

Inhalation of Dry Powder Mannitol Improves Clearance of Mucus in Patients with Bronchiectasis

EVANGELIA DAVISKAS, SANDRA D. ANDERSON, STEFAN EBERL, H-KIM CHAN, and GEORGE BAUTOVICH

Departments of Respiratory and Pet and Nuclear Medicine, Royal Prince Alfred Hospital, Camperdown; and Department of Pharmacy, University of Sydney, Sydney, New South Wales, Australia

Bronchiectasis is a disease characterized by hypersecretion and retention of mucus requiring physical and pharmacologic treatment. Recently we reported that inhalation of dry powder mannitol markedly increases mucociliary clearance (MCC) in asthmatic and in healthy subjects (Daviskas, E., S. D. Anderson, J. D. Brannan, H. K. Chan, S. Eberl, and G. Bautovich. 1997. Inhalation of dry-powder mannitol increases mucociliary clearance. Eur. Respir. J. 10:2449-2454). In this study we investigated the effect of mannitol on MCC in patients with bronchiectasis. Eleven patients 40 to 62 yr of age inhaled mannitol (approximately 300 mg) from a Dinkihaler. MCC was measured over 90 min, in the supine position, on three occasions involving: mannitol or control or baseline, using a radioaerosol technique. On the control day patients reproduced the breathing maneuvers and the number of coughs induced by the mannitol. Mannitol significantly increased MCC over the 75 min from the start of the intervention compared with control and baseline in the whole right lung, central, and intermediate region. Mean (± SEM) clearance with mannitol was 34.0 ± 5.0% versus 17.4 ± 3.8% with control and 11.7 ± 4.4% with baseline in the whole right lung (p < 0.0001). The mean number of coughs induced by mannitol was 49 ± 11. In conclusion, inhalation of dry powder mannitol increased clearance of mucus and thus has the potential to benefit patients with bronchiectasis.

This article has been cited by other articles:

				G. J. Redding, C. Kishioka, P. Martinez, and B. K. Rubin Physical and Transport Properties of Sputum From Children With Idiopathic Bronchiectasis Chest, December 1, 2008; 134(6): 1129 - 1134. [Abstract] [Full Text] [PDF]

				A. Jaques, E. Daviskas, J. A. Turton, K. McKay, P. Cooper, R. G. Stirling, C. F. Robertson, P. T. P. Bye, P. N. LeSouef, B. Shadbolt, et al. Inhaled Mannitol Improves Lung Function in Cystic Fibrosis Chest, June 1, 2008; 133(6): 1388 - 1396. [Abstract] [Full Text] [PDF]

				E. Daviskas, S. D. Anderson, S. Eberl, and I. H. Young Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis Eur. Respir. J., April 1, 2008; 31(4): 765 - 772. [Abstract] [Full Text] [PDF]

				A B Chang and D Bilton Exacerbations in cystic fibrosis: 4 {middle dot} Non-cystic fibrosis bronchiectasis Thorax, March 1, 2008; 63(3): 269 - 276. [Abstract] [Full Text] [PDF]

				M. Sivasankar and K. V. Fisher Vocal Fold Epithelial Response to Luminal Osmotic Perturbation J Speech Lang Hear Res, August 1, 2007; 50(4): 886 - 898. [Abstract] [Full Text] [PDF]

				G.F. Joos and B. O'Connor Indirect airway challenges Eur. Respir. J., June 1, 2003; 21(6): 1050 - 1068. [Abstract] [Full Text] [PDF]

				P.G. Middleton, K.A. Pollard, and J.R. Wheatley Hypertonic saline alters ion transport across the human airway epithelium Eur. Respir. J., February 1, 2001; 17(2): 195 - 199. [Abstract] [Full Text] [PDF]

				E. Daviskas, S. D. Anderson, S. Eberl, H-K. Chan, and I. H. Young The 24-h Effect of Mannitol on the Clearance of Mucus in Patients With Bronchiectasis Chest, February 1, 2001; 119(2): 414 - 421. [Abstract] [Full Text] [PDF]

				J. Zabner, M. P. Seiler, J. L. Launspach, P. H. Karp, W. R. Kearney, D. C. Look, J. J. Smith, and M. J. Welsh The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing PNAS, October 10, 2000; 97(21): 11614 - 11619. [Abstract] [Full Text] [PDF]